One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Risk/benefit trade-offs in rheumatology: rofecoxib revisited in the era of JAK inhibitors
Glen S. Hazlewood
doi : 10.1093/rheumatology/kead388
Rheumatology, Volume 62, Issue 12, December 2023, Pages 3773–3775
Advocating for better trials in rheumatology
Sharanya Kaushik 1 , Mats Junek 2 , Michael Putman
Where did that trial go? Unpublished clinical trials in rheumatology and potential implications
Raisa Lomanto Silva 1 and Sebastian E. Sattui
Exploring and addressing health inequalities in patients with a rheumatic disease: report of a roundtable discussion
Marwan Bukhari 1,2, * and Ernest Choy
Systemic pharmacological treatment of digital ulcers in systemic sclerosis: a systematic literature review
Laura Ross 1, * ,‡ , Nancy Maltez 2,‡ , Michael Hughes 3,4 , Jan W. Schoones 5 , Murray Baron 6 , Lorinda Chung 7 , Dilia Giuggioli 8 , Pia Moinzadeh 9 , Yossra A. Suliman 10 , Corrado Campochiaro 11 , Yannick Allanore 12 , Christopher P. Denton 13,14 , Oliver Distler 15 , Tracy Frech 16 , Daniel E. Furst 17 , Dinesh Khanna 18 , Thomas Krieg 8 , Masataka Kuwana 19 , Marco Matucci-Cerinic 20 , Janet Pope 21 , Alessia Alunno 22
Twenty-five years of novel drug approvals in rheumatology
Kathryn Henry 1 , Natalie Anumolu1 , Michael Putman
Role of IL-6 and IL-6 targeted therapy in systemic lupus erythematosus
Desh Nepal 1, * and David Gazeley
Unpublished clinical trials of common rheumatic diseases
Connor Pedersen 1 , Shannon Tai 1 , Erin Valley 1 , Kathryn Henry 1 , Al ? Duarte-Garc ?a 2 , Shikha Singla 1 , Michael Putman
Cost-effectiveness of cognitive behavioural and personalized exercise interventions for reducing fatigue in inflammatory rheumatic diseases
Huey Yi Chong 1 *, Paul McNamee 1 , Eva-Maria Bachmair 2,3 , Kathryn Martin 4 , Lorna Aucott 5 , Neeraj Dhaun 6 , Emma Dures 7 , Richard Emsley 8 , Stuart R. Gray 9 , Elizabeth Kidd 10 , Vinod Kumar 11 , Karina Lovell 12 , Graeme MacLennan 5 , John Norrie 13 , Lorna Paul 14 , Jonathan Packham 15 , Stuart H. Ralston 16 , Stefan Siebert 2 , Alison Wearden12 , Gary Macfarlane 3,4 , Neil Basu 2 , LIFT Study Group
COVID-19 infection, admission and death and the impact of corticosteroids among people with rare autoimmune rheumatic disease during the second wave of COVID-19 in England: results from the RECORDER Project
Megan Rutter 1,2,3 *, Peter C. Lanyon 1,2,3,4 , Matthew J. Grainge 1 , Richard Hubbard 1,4 , Mary Bythell 3 , Peter Stilwell 3 , Jeanette Aston3 , Sean McPhail 3 , Sarah Stevens 3 , Fiona A. Pearce
Flares in autoimmune rheumatic diseases in the post-COVID-19 vaccination period—a cross-sequential study based on COVAD surveys
Kshitij Jagtap 1 , R. Naveen 2 , Jessica Day 3,4,5 , Parikshit Sen 6 , Binit Vaidya 7 , Arvind Nune 8 , Elena Nikiphorou 9,10 , Ai Lyn Tan 11,12 , Vishwesh Agarwal 13 , Sreoshy Saha 14 , Samuel Katsuyuki Shinjo 15 , Nelly Ziade 16,17 , Mrudula Joshi 18 , Tsvetelina Velikova 19 , Marcin Milchert 20 , Ioannis Parodis 21,22 , Abraham Edgar Gracia-Ramos 23 , Lorenzo Cavagna 24 , Masataka Kuwana 25 , Johannes Knitza 26 , Ashima Makol 27 , Aarat Patel 28 , John D. Pauling 29,30 , Chris Wincup 31,32 , Bhupen Barman 33 , Erick Adrian Zamora Tehozol 34 , Jorge Rojas Serrano 35 , Ignacio Garc ?a-De La Torre 36 , Iris J. Colunga-Pedraza 37 , Javier Merayo-Chalico 38 , Okwara Celestine Chibuzo 39 , Wanruchada Katchamart 40 , Phonpen Akawatcharangura Goo 41 , Russka Shumnalieva 42 , Yi-Ming Chen 43,44 , Leonardo Santos Hoff 45 , Lina El Kibbi 46 , Hussein Halabi 47 , Syahrul Sazliyana Shaharir 48 , A. T. M. Tanveer Hasan 49 , Dzifa Dey 50 , Carlos Enrique Toro Gutie´ rrez 51 , Carlo Vinicio Caballero-Uribe 52 , James B. Lilleker 53,54 , Babur Salim 55 , Tamer Gheita 56 , Tulika Chatterjee 57 , Miguel A. Saavedra 58 , Oliver Distler 59 , COVAD Study Group § , Hector Chinoy 53,60,61 , Vikas Agarwal 2 , Rohit Aggarwal 62,‡ , Latika Gupta
Etanercept originator versus etanercept biosimilar for the treatment of rheumatoid arthritis as a first biologic: results from the BSRBR-RA
Lianne Kearsley-Fleet 1,‡ , Aasiyah Rokad 1,‡ , Man-Fung Tsoi1 , Sizheng Steven Zhao 1 , Mark Lunt 1 , Kath D. Watson1 , BSRBR-RA Contributors Group 1 , Kimme L. Hyrich
Risk of severe infections after the introduction of biologic DMARDs in people with newly diagnosed rheumatoid arthritis: a population-based interrupted time-series analysis
Vivienne Y. Zhou 1,2 , Diane Lacaille 1,3 , Na Lu1 , Jacek A. Kopec 1,4 , Yi Qian 5 , Bohdan Nosyk 2,6 , J. Antonio Avi~na-Zubieta 1,3 , John M. Esdaile 1,3 , Hui Xie
Characteristics of patients with difficult-to-treat rheumatoid arthritis in a French single-centre hospital
Sophie Hecquet 1,2 , Alice Combier 1 , Alexia Steelandt 1 , Marion Pons1 , Daniel Wendling 2 , Anna Molto 1 , Corinne Miceli-Richard 1 , Yannick Allanore 1 , Je´ roˆ me Avouac
Metabolic and inflammatory profiles define phenotypes with clinical relevance in female knee osteoarthritis patients with joint effusion
Joan Calvet 1,2, *, Mar ?a Garc ?a-Manrique 1,2 , Antoni Berenguer-Llergo 3 , Cristo´ bal Orellana 1 , Silvia Garcia Cirera 1 , Maria Llop 1 , Carlos Galisteo Lencastre 1 , Marta Are´ valo 1 , Cristina Aymerich 1 , Rafael Go´ mez 1 , Ne´ stor Albi~nana Gime´ nez4 , Jordi Grataco´ s
Course and predictors of work productivity in gout — results from the NOR-Gout longitudinal 2-year treat-to-target study
Till Uhlig 1,2 *, Lars F. Karoliussen 1 , Joe Sexton 1 , Sella Aarrestad Provan 1,3 , Tore K. Kvien1,2 , Espen A. Haavardsholm 1,2 , Hilde Berner Hammer
New bone formation at the sacroiliac joint in axial spondyloarthritis: characterization of backfill in MRI and CT
Torsten Diekhoff 1, *, Denis Poddubnyy 2 , Fabian Proft 2 , Katharina Ziegeler 1 , Dominik Deppe 1 , Christoph Niedermeier 1 , Kay Geert A. Hermann
Clusters based on demography, disease phenotype, and autoantibody status predicts mortality in lupus: data from Indian lupus cohort (INSPIRE)
Chengappa Kavadichanda 1,‡ , Sachit Ganapathy 2,‡ , Deepika Kounassegarane 1 , Liza Rajasekhar 3 , Bhavani Dhundra 3 , Akansha Srivastava4 , Sandra Manuel 5 , Vineeta Shobha 5 , C. Brilly Swarna 6 , Ashish J. Mathew 6 , Dalbir Singh 7 , Manish Rathi 7 , Saumya Ranjan Tripathy 8 , Bidyut Das 8 , Md Dilshad Akhtar 9 , Ranjan Gupta 9 , Avinash Jain10 , Parasar Ghosh11 , Vir Singh Negi 1,a , Amita Aggarwal 3 *, for the INSPIRE Group
Comparisons of SLE-DAS and SLEDAI-2K and classification of disease activity based on the SLE-DAS with reference to patient-reported outcomes
Akira Onishi 1, *, Hideaki Tsuji 2 , Yudai Takase 2 , Yuto Nakakubo 2 , Takeshi Iwasaki2 , Tomohiro Kozuki2 , Tsuneyasu Yoshida 2 , Mirei Shirakashi 2 , Hideo Onizawa 1 , Ryosuke Hiwa2 , Koji Kitagori 2 , Shuji Akizuki 2 , Ran Nakashima 2 , Hajime Yoshifuji 2 , Masao Tanaka1 , Akio Morinobu
Sensitivity analysis of EQ-5D-3L index scores in terms of discriminative and known-groups validity in SLE: introducing Adequate Health State
Nicole Hua1 , Alvaro Gomez1 , Julius Lindblom 1 , Sharzad Emamikia 1 , Yvonne Enman 1,2 , David Grannas 3 , Emelie Heintz 4 , Malin Regardt 5,6 , Ioannis Parodis
Association between hypogammaglobulinaemia and severe infections during induction therapy in ANCA-associated vasculitis: from J-CANVAS study
Satoshi Omura 1,2 , Takashi Kida 1 , Hisashi Noma 3 , Atsuhiko Sunaga 1,2 , Hiroaki Kusuoka 1,2 , Masatoshi Kadoya 2 , Daiki Nakagomi 4 , Yoshiyuki Abe 5 , Naoho Takizawa 6 , Atsushi Nomura7 , Yuji Kukida 8 , Naoya Kondo 9 , Yasuhiko Yamano 10 , Takuya Yanagida2,11 , Koji Endo 12 , Shintaro Hirata 13 , Kiyoshi Matsui 14 , Tohru Takeuchi 15 , Kunihiro Ichinose 16,17 , Masaru Kato 18 , Ryo Yanai19 , Yusuke Matsuo 20,21 , Yasuhiro Shimojima 22 , Ryo Nishioka 23 , Ryota Okazaki 24 , Tomoaki Takata 25 , Takafumi Ito 26 , Mayuko Moriyama 17 , Ayuko Takatani 27 , Yoshia Miyawaki 28 , Toshiko Ito-Ihara 29 , Nobuyuki Yajima 18,30,31 , Takashi Kawaguchi 32 , Wataru Fukuda 2 , Yutaka Kawahito
Anti-SAE autoantibody in dermatomyositis: original comparative study and review of the literature
Juliette Demortier 1,‡ , Mathieu Vautier 2,‡ , Olivier Chosidow 3 , Laure Gallay 4 , Didier Bessis 5 , Alice Berezne 6 , Nade` ge Cordel 7 , Jean Schmidt 8 , Amar Smail 8 , Pierre Duffau 9 , Marie Jachiet10 , Edouard Begon 11 , Jeremy Gottlieb 12 , Franc¸ois Chasset 13 , Julie Graveleau 14 , Myriam Marque 15 , Elise Cesbron 16 , Amandine Forestier 17 , Se´ verine Josse 18 , Nicolas Kluger 19 , Caroline Beaucheˆ ne 20 , Yannick Le Corre 21 , Valentine Pagis 22 , Aude Rigolet 2 , Perrine Guillaume-Jugnot 2 , Franc¸ois-Je´ roˆ me Authier 23 , Nelly Guilain 24 , Nathalie Streichenberger25 , Sarah Leonard-Louis 26 , Samia Boussouar 27 , Oce´ ane Landon-Cardinal 28 , Olivier Benveniste 2 , Yves Allenbach
Increased risk for stroke in patients with familial Mediterranean fever: results from a large population-based study
Niv Ben-Shabat 1,2,3, *, Omer Gendelman 1,2,3 , Lior Fisher 1,2,3 , Uria Shani1,2,3 , Yonatan Shneor Patt 1,2,3 , Abdulla Watad 1,2,3,4 , Vita Skuja 5,6 , Dennis McGonagle 4,7 , Howard Amital
Targeted testing of bone marrow specimens with cytoplasmic vacuolization to identify previously undiagnosed cases of VEXAS syndrome
Alexander S. Hines 1, *,‡ , Matthew J. Koster 2,‡ , Allison R. Bock 3 , Ronald S. Go 3 , Kenneth J. Warrington 2 , Horatiu Olteanu 4 , Terra L. Lasho 3 , Mrinal M. Patnaik 3,§ , Kaaren K. Reichard
Prevalence of LTBI in patients with autoimmune diseases and accuracy of IGRA in predicting TB relapse
S. Chandrashekara 1, *, Renuka Panchagnula 2 , Yogitha Chennupati
Discordance between patient- and physician-reported disease activity in adult idiopathic inflammatory myopathy
Shiri Keret 1,†, Didem Saygin 2,†, Siamak Moghadam-Kia 2 , Dianxu Ren 3 , Chester V. Oddis2 , Rohit Aggarwal 2, *
The predictors of paradoxical reactions, especially psoriasis, to biologic therapy—findings from the TReasure database: a 5-year follow-up study
Burcu Yagiz 1, *, Nihal Lermi 1 , Belkis N. Coskun 1 , Ediz Dalkilic 1 , Sedat Kiraz 2 , Abdulsamet Erden 3 , Ihsan Ertenli 2 , Emine Duran 2 , Emre Bilgin 2 , Recep Y?lmaz 4 , As¸k?n Ates¸ 4 , Abdurrahman Tufan 5 , Hamit Ku¨ c¸u¨ k 5 , Ridvan Mercan 6 , Haluk Cinakl? 7 , Servet Akar 7 , Nazife S¸. Yas¸ar Bilge 8 , Timucin Kas¸ifoglu 8 , Su¨ meyye M. Tu¨ rk 9 , Emel Orge Gonullu 9 , Cemal Bes 10 , Nilufer Alpay Kanitez 11 , Hakan Emmungil
N-glycan in the variable region of monoclonal ACPA (CCP-Ab1) promotes the exacerbation of experimental arthritis
Masatoshi Kawataka1,2,†, Kazuhisa Ouhara 3,†, Eiji Kobayashi 1 , Koichiro Shinoda 2 , Kazuyuki Tobe 2 , Ryousuke Fujimori 3 , Noriyoshi Mizuno 3 , Eiji Sugiyama 4 , Tatsuhiko Ozawa 1,5, *, Hiroyuki Kishi
Early-onset gout and rare deficient variants of the lactate dehydrogenase D gene
Thomas Bardin 1,2, *, Yves-Marie Ducrot 3 , Quang Nguyen 2 , Emmanuel Letavernier 4 , Jeremy Zaworski 4 , Hang-Korng Ea1 , Fre´ deric Touzain5 , Minh Duc Do 6 , Julien Colot 7 , Yann Barguil 7 , Antoine Biron 7 , Matthieu Resche-Rigon 8 , Pascal Richette 1 , Corinne Collet
Intestinal uric acid excretion contributes to serum uric acid decrease during acute gout attack
Tianyi Zhao 1,2,‡ , Ling Cao1,2,‡ , Cong Lin 1,2 , Rui Xu 1,2 , Xingchen Du 1,2 , Mengmeng Zhou 1,2 , Xue Yang 1,2 , Weiguo Wan1,2 , Hejian Zou 1,2 , Xiaoxia Zhu
The role of antidrug antibodies in ustekinumab therapy and the impact of methotrexate
Sorwe Mojtahed Poor 1,2 *, Marina Henke 2 , Thomas Ulsho¨ fer2 , Michaela Ko¨ hm 1,2 , Frank Behrens 1,2 , Harald Burkhardt 1,2 , Susanne Schiffmann
CCL20 inhibition for treating inflammation in ankylosing spondylitis
Eun Jeong Won1,‡ , Hui-Ju Kim 2,‡ , Yu Jeong Lee2 , Moon-Ju Kim3 , Hae-In Lee3 , Hyun Hee Jang 2 , Seong Hoon Kim 2 , Ji-Hyoun Kang 3 , Ki-Jeong Park3 , Seung Cheol Shim 4 , Sungsin Jo5 , Tae-Hwan Kim 6,§ , Tae-Jong Kim
Efgartigimod restores muscle function in a humanized mouse model of immune-mediated necrotizing myopathy
Sarah Julien 1 , Bas van der Woning 2 , Leentje De Ceuninck2 , Emma Briand 1 , Thara Jaworski 1 , Gae¨ lle Roussel1 , Rachid Zouba?¨ri 1 , Yves Allenbach 3 , Olivier Benveniste3 , Laurent Drouot1,‡ , Olivier Boyer
Correction: Comparison of risks of cancer, infection, and MACEs associated with JAK inhibitor and TNF inhibitor treatment: a multicentre cohort study
Mechanic’s hands are associated with interstitial lung disease in myositis patients regardless of the presence of antisynthetase antibodies
Matilde Bandeira 1,2, * ,‡ , Eduardo Dourado 1,2,‡ , Ana T. Melo 1,2 , Patr ?cia Martins 1,2 , Vanessa Fraga3 , Jose´ L. Ferraro 4 , Andre´ Saraiva 5 , Marlene Sousa 5 , Hugo Parente 6 , Catarina Soares6 , Ana M. Correia 7 , Diogo E. Almeida 7 , Sara P. Dinis 8 , Ana S. Pinto 8 , Filipe O. Pinheiro 9 , Maria S. Rato 9 , Tiago Beir~ao 10 , Beatriz Sam~oes 10 , Bernardo Santos 11 , Carolina Mazeda 11 , Ana T. Ch ?charo 12 , Margarida Faria 13 , Agna Neto 13 , Maria H. Lourenc¸o 14 , Lu ?sa Brites 15 , Mar ?lia Rodrigues 15 , Joana Silva-Dinis16 , Jo~ao M. Dias 17 , Filipe C. Arau´ jo 18 , Na´ dia Martins 19 , Maura Couto 19 , Ana Valido 20 , Maria J. Santos 2,3 , Sofia Barreira 1,2 , Jo~ao E. Fonseca 1,2 Raquel Campanilho-Marques
Characterizing primary hospitalizations for systemic lupus erythematosus in the United States
Amar D. Desai 1 , Victoria P. Werth 2,3 , Scott A. Elman
Lenalidomide for treatment of refractory aphthosis and neutrophilic pustulosis in familial pyrin-associated autoinflammation with neutrophilic dermatosis
Laura Poujade 1 , Guillaume Sarrabay 2 , Renaud Cezar 3 , Quentin Samaran 1 , Pierre Corbeau 3 , Didier Bessis 1 , Tu-Anh Tran
Peripheral ulcerative keratitis as the first and only manifestation of MPO-ANCA-associated vasculitis
Ana Paula Couto 1, *, Veroˆ nica Mello2 , Gabriel Conde Motta 1 , Bruno F. Fernandes 3 , Ana Carolina Vieira
Giant cell arteritis of the prostate
Sharon Cowley 1 *, Patricia Harkins 1 , C. Kirby 1 , Micheal Hanly 2 , Arun Thomas 3 , David Kane
Mycophenolate mofetil as induction and long-term maintenance therapy in childhood cerebral vasculitis: a case series
Ilaria Pagnini 1,‡ , Marzia Mortilla 2,‡ , Diletta Gentile 3 , Ilaria Maccora 1 , Sarah Abu-Rumeileh 1 , Nicola Limbucci4 , Gabriele Simonini 1 , Anna Rosati
Comment on: Anti-acid therapy in SSc-associated interstitial lung disease: long-term outcomes from the German Network for Systemic Sclerosis
Onofre Moran-Mendoza 1,2, *, Ahmad Al-Jarallah 1,2 , Salem Alqahtani 1,2 , Carla Paredes
Comment on: Anti-acid therapy in SSc-associated interstitial lung disease: long-term outcomes from the German Network for Systemic Sclerosis—caution is key in interpreting retrospective data: Reply
Michael Kreuter 1, *, Francesco Bonella 2 , Pia Moinzadeh 3,‡ , Nicolas Hunzelmann
Comment on: AI am a rheumatologist: a practical primer to large language models for rheumatologists
Amnuay Kleebayoon 1, * and Viroj Wiwanitkit
Comment on: AI am a rheumatologist: a practical primer to large language models for rheumatologists: reply
Vincenzo Venerito 1,‡ , Emre Bilgin 2,‡, *, Florenzo Iannone 1,§ , Sedat Kiraz
Chronic non-bacterial osteomyelitis in SAPHO syndrome complicated by subclavian vein obstruction
Anne T. Leerling 1,2, *, Ana Navas Ca~nete2,3 , Elizabeth M. Winter
Follow-up imaging of SAPHO syndrome treated with denosumab
Grigorios T. Sakellariou 1, *, Nikolaos Chaitidis 1 , Ioannis Tsifountoudis
Bezoar secondary to NSAID use in a patient with inflammatory arthritis
Miriam F. Cox 1, *, Eleanor Pilsworth 1 , Muhammad Kazmi
Sparing of tuberculin sensitivity test site in a psoriatic arthritis patient with a flare of psoriasis
Kavita Poonia 1, * and Pratika Goyal
